Dr. Anteneh A. Tesfaye
Claim this profileWayne State University/Karmanos Cancer Institute
Studies Colorectal Cancer
Studies Tumors
18 reported clinical trials
37 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage IV
BRAF negative
2Tumors
Stage IV
Stage III
dMMR positive
Affiliated Hospitals
Wayne State University/Karmanos Cancer Institute
MedStar Washington Hospital Center
Clinical Trials Anteneh A. Tesfaye is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting2 awards Phase 312 criteria
More about Anteneh A. Tesfaye
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Anteneh A. Tesfaye has experience with
- Fluorouracil
- Dostarlimab
- Capecitabine
- Oxaliplatin
- Irinotecan Hydrochloride
- Nab-paclitaxel
Breakdown of trials Anteneh A. Tesfaye has run
Colorectal Cancer
Tumors
Neuroendocrine Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anteneh A. Tesfaye specialize in?
Anteneh A. Tesfaye focuses on Colorectal Cancer and Tumors. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage IV.
Is Anteneh A. Tesfaye currently recruiting for clinical trials?
Yes, Anteneh A. Tesfaye is currently recruiting for 7 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Anteneh A. Tesfaye has studied deeply?
Yes, Anteneh A. Tesfaye has studied treatments such as Fluorouracil, Dostarlimab, Capecitabine.
What is the best way to schedule an appointment with Anteneh A. Tesfaye?
Apply for one of the trials that Anteneh A. Tesfaye is conducting.
What is the office address of Anteneh A. Tesfaye?
The office of Anteneh A. Tesfaye is located at: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Wayne State University/Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.